Litcius/Paper detail

Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis

Simone M. Goldinger, Kristina Buder‐Bakhaya, Serigne Lo, Andrea Forschner, Meredith McKean, Lisa Zimmer, Chloe Khoo, Reinhard Dummer, Zeynep Eroglu, Elizabeth I. Buchbinder, Paolo A. Ascierto, Ralf Gutzmer, Elisa A. Rozeman, Christoph Höeller, Douglas B. Johnson, Anja Gesierich, Peter Kölblinger, Naima Bennannoune, Justine V. Cohen, Katharina C. Kähler, Melissa Wilson, Jonathan Cebon, Victoria Atkinson, Jessica L. Smith, Olivier Michielin, Georgina V. Long, Jessica C. Hassel, Benjamin Weide, Lauren E. Haydu, Dirk Schadendorf, Grant A. McArthur, Patrick A. Ott, Christian U. Blank, Caroline Robert, Ryan J. Sullivan, Axel Hauschild, Matteo S. Carlino, Claus Garbe, Michael A. Davies, Alexander M. Menzies

2021European Journal of Cancer55 citationsDOI

Topics & Concepts

MedicineDacarbazineInternal medicineChemotherapyOncologyMelanomaCarboplatinTemozolomideProgressive diseaseProgression-free survivalSurgeryCancer researchCisplatinCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementMelanoma and MAPK Pathways
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis | Litcius